{"id":14379,"date":"2021-07-21T08:41:58","date_gmt":"2021-07-21T06:41:58","guid":{"rendered":"https:\/\/ggba.swiss\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/"},"modified":"2023-07-04T13:40:19","modified_gmt":"2023-07-04T11:40:19","slug":"geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/","title":{"rendered":"GeNeuro raises EUR 6 million for multiple sclerosis treatment"},"content":{"rendered":"<p>Pursuing a novel approach for treating autoimmune diseases by seeking to block mechanisms suspected of participating to their onset and development, <a href=\"http:\/\/www.geneuro.com\/\" target=\"_blank\" rel=\"noopener\">GeNeuro<\/a> develops safe and effective treatments against neurological disorders and autoimmune diseases, such as multiple sclerosis.<\/p>\n<p>GeNeuro\u2019s technology works by neutralizing causal factors encoded by <a href=\"http:\/\/www.geneuro.com\/en\/technologies\/rationale\" target=\"_blank\" rel=\"noopener\">HERVs <\/a>(human endogenous retrovirus), which represent 8% of human DNA. The company, which is headquartered in Geneva with R&amp;D facilities in Lyon, France, has the rights to 17 patent families protecting its technology.<\/p>\n<p>The biotech has announced results\u00a0from its CHANGE-MS and ANGEL-MS clinical studies on its drug candidate temelimab for<em>\u00a0<\/em>multiple sclerosis. The study, held at the <a href=\"https:\/\/ki.se\/en\" target=\"_blank\" rel=\"noopener\">Karolinska Institutet<\/a> in Stockholm, confirmed the safety and efficacy of temelimab on MRI markers of inflammation and neurodegeneration.<\/p>\n<p>These results putting temelimab in a unique position against neurodegeneration in MS, GeNeuro was able to raise EUR 6 million through a private placement.\u00a0<\/p>\n<p>The net proceeds will primarily allow the company to fund its operations and extend its financial visibility until the end of 2022 in order to facilitate Phase 3 planning and partnering discussions for temelimab.<\/p>\n<p>Jes\u00fas Martin-Garcia, CEO of GeNeuro, states that: \u201cthe capital will also support continuing preclinical research on the potential of temelimab for Post-COVID patients with neuropsychiatric affections, notably through the partnerships with the <a href=\"https:\/\/ciri.ens-lyon.fr\/accueil-ciri?set_language=en&amp;cl=en\" target=\"_blank\" rel=\"noopener\">CIRI<\/a> (International Center for Infectiology Research, France) and <a href=\"https:\/\/www.fondation-fondamental.org\/\" target=\"_blank\" rel=\"noopener\">Fondation FondaMental<\/a>, which seek to speed up the development of diagnostic and therapeutic solutions.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GeNeuro, a Geneva-based biopharmaceutical company developing new treatments for neurodegenerative diseases, has raised EUR 6 million through a private placement.<\/p>\n","protected":false},"author":3,"featured_media":14380,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[912,894,911],"class_list":["post-14379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-biotech","tag-financing","tag-pharma"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GeNeuro raises EUR 6 million for multiple sclerosis treatment - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GeNeuro raises EUR 6 million for multiple sclerosis treatment - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"GeNeuro, a Geneva-based biopharmaceutical company developing new treatments for neurodegenerative diseases, has raised EUR 6 million through a private placement.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-21T06:41:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:40:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"GeNeuro raises EUR 6 million for multiple sclerosis treatment\",\"datePublished\":\"2021-07-21T06:41:58+00:00\",\"dateModified\":\"2023-07-04T11:40:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/\"},\"wordCount\":241,\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg\",\"keywords\":[\"Biotech\",\"Financing\",\"Pharma\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/\",\"name\":\"GeNeuro raises EUR 6 million for multiple sclerosis treatment - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg\",\"datePublished\":\"2021-07-21T06:41:58+00:00\",\"dateModified\":\"2023-07-04T11:40:19+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GeNeuro raises EUR 6 million for multiple sclerosis treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GeNeuro raises EUR 6 million for multiple sclerosis treatment - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/","og_locale":"en_US","og_type":"article","og_title":"GeNeuro raises EUR 6 million for multiple sclerosis treatment - Greater Geneva Bern area","og_description":"GeNeuro, a Geneva-based biopharmaceutical company developing new treatments for neurodegenerative diseases, has raised EUR 6 million through a private placement.","og_url":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-07-21T06:41:58+00:00","article_modified_time":"2023-07-04T11:40:19+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mathieu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#article","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"GeNeuro raises EUR 6 million for multiple sclerosis treatment","datePublished":"2021-07-21T06:41:58+00:00","dateModified":"2023-07-04T11:40:19+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/"},"wordCount":241,"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg","keywords":["Biotech","Financing","Pharma"],"articleSection":["Life sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/","url":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/","name":"GeNeuro raises EUR 6 million for multiple sclerosis treatment - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#primaryimage"},"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg","datePublished":"2021-07-21T06:41:58+00:00","dateModified":"2023-07-04T11:40:19+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/MS-Brain-Shutterstock-630x380-4.jpg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/staging.ggba.swiss\/en\/geneuro-raises-eur-6-million-for-multiple-sclerosis-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"GeNeuro raises EUR 6 million for multiple sclerosis treatment"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/en\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=14379"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14379\/revisions"}],"predecessor-version":[{"id":16970,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14379\/revisions\/16970"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/14380"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=14379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=14379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=14379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}